1. Demo data
The demo data is a GWAS of rheumatoid arthritis (RA) from WTCCC,
2007 [1]. The result of this GWAS includes ~ 455 K GWAS SNP P-values and 154 most significant SNPs
with P-value < 10-5.
So the input data for the demo run:
1) GWAS SNP P-value data: gz
txt (required input)
Download
gz Download txt
2) Most significant SNPs: txt (optional
input, which can be exacted automatically from 1) by setting P-value
< 10-5) Download
2. Demo run
1) Parameters
Use the default parameters as shown in the homepage.
2) Result
Utilizing the ~ 455 K GWAS SNP P-values as input and the 154 SNPs as the most significant SNPs,
with default parameters, ICSNPathway identified two candidate causal SNPs
(rs2476601 and rs2230926) and two candidate causal pathways (‘protein tyrosine phosphatase
activity’ and ‘CD
Hypotheses
[rs2476601 (non-synonymous, deleterious) -> PTPN22 -> protein tyrosine phosphatase activity]
[rs2230926 (non-synonymous) -> TNFAIP3 -> CD
Table 1
Candidate causal SNPs of RA.
Candidate causal SNP |
Functional class |
Gene |
Candidate causal pathway a |
-log10(P) b |
In LD with |
r2 |
D' |
-log10(P) c |
rs2476601 |
non-synonymous (deleterious) |
PTPN22 |
1 |
- |
rs6679677 |
1.0 |
1.0 |
25.5 |
rs2230926 |
non-synonymous |
TNFAIP3 |
2 |
- |
rs5029939 |
1.0 |
1.0 |
5.5 |
a The
number indicates the index of pathways, which are ranked by their statistical
significance (FDR).
b -log10(P) for candidate causal SNP in original GWAS. '-' denotes that this
SNP is not represented in the original GWAS.
c -log10(P) for the SNP (which the candidate
causal SNP is in LD with) in original GWAS.
Table 2
Candidate causal pathways of RA.
Index |
Candidate pathway |
Nominal P |
FDR |
1 |
protein tyrosine phosphatase activity (GO:0004725) |
0.004 |
0.041 |
2 |
CD |
0.010 |
0.042 |
References
[1] WTCCC. (2007) Genome-wide association study of 14,000 cases of
seven common diseases and 3,000 shared controls. Nature, 447, 661-678.
[2] Plenge, R.M., Seielstad, M., Padyukov, L., Lee, A.T.,
Remmers, E.F., Ding, B., Liew, A., Khalili, H., Chandrasekaran, A., Davies,
L.R. et al. (2007) TRAF1-C5 as a risk
locus for rheumatoid arthritis--a genomewide study.
[3] Gregersen, P.K., Amos, C.I., Lee, A.T., Lu, Y., Remmers,
E.F., Kastner, D.L., Seldin, M.F., Criswell, L.A., Plenge, R.M., Holers, V.M. et al. (2009) REL, encoding a member of
the NF-kappaB family of transcription factors, is a newly defined risk locus
for rheumatoid arthritis. Nat Genet, 41, 820-823.
[4] Stahl, E.A., Raychaudhuri, S., Remmers, E.F., Xie, G., Eyre,
S., Thomson, B.P., Li, Y., Kurreeman, F.A., Zhernakova, A., Hinks, A. et al. (2010) Genome-wide association
study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet, 42, 508-514.
[5] Kochi, Y., Okada, Y., Suzuki, A., Ikari, K., Terao, C.,
Takahashi, A., Yamazaki, K., Hosono, N., Myouzen, K., Tsunoda, T. et al. (2010) A regulatory variant in
CCR6 is associated with rheumatoid arthritis susceptibility. Nat Genet, 42, 515-519.
[6] Fiorillo, E., Orru, V., Stanford, S.M., Liu, Y., Salek, M., Rapini,
N., Schenone, A.D., Saccucci, P., Delogu, L.G., Angelini, F. et al. (2010) Autoimmune-associated
PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an
inhibitory tyrosine residue. J Biol Chem,
285, 26506-26518.
[7] Musone, S.L., Taylor, K.E., Lu, T.T., Nititham, J.,
Ferreira, R.C., Ortmann, W., Shifrin, N., Petri, M.A., Kamboh, M.I., Manzi, S. et al. (2008) Multiple polymorphisms in
the TNFAIP3 region are independently associated with systemic lupus
erythematosus. Nat Genet, 40, 1062-1064.